About Kathy Sharrard

This author has not yet filled in any details.
So far Kathy Sharrard has created 52 blog entries.

Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers

2023-03-07T10:05:36+09:30December 15th, 2021|News, Uncategorised|

Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the University Hospital of Ludwig-Maximillian University of Munich (LMU). The agreement

Manufacture of Carina’s LGR5 CAR-T has begun with CellVec contracted to produce GMP-grade lentivirus constructs

2021-11-09T11:02:58+09:30November 9th, 2021|News|

Singapore-based CellVec will manufacture clinical-grade lentivirus – the first critical step in making LGR5 CAR-T cells for a first-in-human clinical trial for patients with advanced colorectal (bowel) cancer in late

Researcher in focus… Emma Thompson, PhD candidate and Carina researcher

2023-05-08T18:38:52+09:30July 14th, 2021|News, Science|

Emma Thompson is a PhD candidate in Professor Claudine Bonder's Vascular Biology & Cell Trafficking Laboratory at UniSA's Centre for Cancer Biology. Emma's research is focused on testing Carina Biotech's LGR5-targeting CAR-T

Go to Top